Ownership history in Squarepoint Ops LLC · 28 quarters on record
This page tracks every 13F SEC filing in which Squarepoint Ops LLC reported a position in FATE THERAPEUTICS INC (FATE). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 15,554 | -2,205 | -12.4% | 0.00% | $20K | $1.26 |
| 2025 Q2 | REDUCED | 17,759 | -16,536 | -48.2% | 0.00% | $20K | $1.12 |
| 2024 Q4 | ADDED | 34,295 | +20,805 | +154.2% | 0.00% | $57K | $1.65 |
| 2024 Q3 | REDUCED | 13,490 | -115,269 | -89.5% | 0.00% | $47K | $3.50 |
| 2024 Q2 | REDUCED | 128,759 | -47,736 | -27.0% | 0.00% | $422K | $3.28 |
| 2023 Q4 | REDUCED | 176,495 | -98,306 | -35.8% | 0.00% | $660K | $3.74 |
| 2023 Q3 | ADDED | 274,801 | +210,582 | +327.9% | 0.00% | $583K | $2.12 |
| 2023 Q2 | REDUCED | 64,219 | -60,000 | -48.3% | 0.00% | $306K | $4.76 |
| 2023 Q1 | REDUCED | 124,219 | -471,016 | -79.1% | 0.00% | $708K | $5.70 |
| 2022 Q4 | ADDED | 595,235 | +582,028 | +4407.0% | 0.02% | $6.0M | $10.09 |
As of 2025 Q4 — sorted by position size